Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed ...

I am not a doctor and the following information may not be 100% accurate but, to the best of my ability, the intention of ...

It’s wintertime in the Northern Hemisphere, and for many people that means having the spotlight on your body’s largest ...

BOCA RATON, FLORIDA - INmune Bio , Inc. (NASDAQ: NASDAQ:INMB), a clinical-stage biotechnology company with a market capitalization of $212.74 million, announced today its plans to submit regulatory ...

Our kidneys have a very specific and important role in keeping our body healthy. They filter waste, balance fluids, and ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) announced better-than-expected revenue in Q4 CY2024, with sales up ...

Natera, Inc. , a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) molecular residual disease (MRD) testing in the ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Breast cancer is common among Indian women, with early detection crucial for better outcomes. Symptoms include lumps, changes ...

As of Feb. 1, 21.2 per cent of tests have come back positive for influenza. Since Aug. 25, 2024, a total of 76 influenza-associated deaths were reported in Canada.